Key Points
- Wife Rebecca Gayheart and daughters Billie and Georgia were at his side.
- He publicly announced his ALS diagnosis in April 2025 after early 2024 symptoms.
- A passionate advocate for ALS awareness and research; family has requested privacy.
ERIC Dane has died after a brave battle with ALS.
The Grey’s Anatomy star passed away on Thursday with his wife, Rebecca Gayheart, and daughters Billie and Georgia by his side. He was 53.
“With heavy hearts, we share that Eric Dane passed on Thursday afternoon following a courageous battle with ALS,” said a statement to Pop Quest.
“He spent his final days surrounded by dear friends, his devoted wife, and his two beautiful daughters, Billie and Georgia, who were the center of his world.
“Throughout his journey with ALS, Eric became a passionate advocate for awareness and research, determined to make a difference for others facing the same fight.
“He will be deeply missed, and lovingly remembered always. Eric adored his fans and is forever grateful for the outpouring of love and support he’s received.
“The family has asked for privacy as they navigate this impossible time.”
Eric had been battling ALS, a fatal neurodegenerative disease also known as amyotrophic lateral sclerosis or Lou Gehrig’s disease, since early 2024, when he first began experiencing symptoms.
He announced his diagnosis in April 2025.
“I have no reason to be in a good spirit at any time, on any given day,” Eric said.
“I don’t think anybody would blame me if I went upstairs in my bedroom, crawled under the sheets, and spent the next two weeks crying.
“I’m not about to concede my purpose for some disease. I just am not capable of doing that.
“I’m fairly limited in what I can do physically as an actor, but I still have my brain, and I still have my speech, so I’m willing to do just about anything.”
Why This Matters
Eric Dane’s death underscores the human toll of ALS, highlighting his shift from beloved actor to vocal advocate whose openness raised awareness and urgency for research, inspiring fans and industry colleagues to push for better treatments.
